Sandra von Meier

Sandra von Meier currently serves as the VP of Business Development at Desitin Arzneimittel GmbH, a position held since May 2025. Prior to this role, Sandra was involved in business development activities at Career Transition for a brief period in 2025. From June 2022 to February 2025, Sandra led the Business Development & Licensing team at Debiopharm, overseeing in and out-licensing initiatives. Sandra's previous experience includes serving as Senior Director of Scientific Licensing for Oncology at Bayer from May 2021 to June 2022 and as Director of Oncology Licensing & Business Development at the Healthcare Business of Merck from April 2014 to May 2021. Educational qualifications include a Doctor of Arts in Biology from UCL and a Diploma in Biochemistry from Freie Universität Berlin.